{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:54:23Z","timestamp":1778028863926,"version":"3.51.4"},"reference-count":72,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"45","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:sec><jats:title>Abstract<\/jats:title><jats:p>Although longer duration of untreated psychosis (DUP) is associated with poor response to antipsychotic treatment, it remains unclear whether it independently influences time to symptomatic remission in first-episode psychosis (FEP). This study examined rate of symptomatic remission, and explored if DUP, premorbid functioning, global functioning, insight and socio-demographic characteristics were independently associated with time to symptomatic remission in FEP.<\/jats:p><jats:p>This prospective study enrolled 126 FEP patients (aged 18\u201365) between June 2009 and September 2012. Subjects were followed-up monthly over 18 months after they had received antipsychotic medication. Remission in positive and negative symptoms was defined as in the Remission in Schizophrenia Working Group (RSWG) criteria. Subjects were defined as \u201cin symptomatic remission\u201d if they remitted in both negative and positive symptoms. At baseline, the following explanatory variables were measured: socio-demographic characteristics; DUP as short (\u22645 months) and long (&gt;5 months); premorbid functioning as deteriorating, stable poor, and stable good according to Cannon-Spoor Premorbid Adjustment Scale; global functioning as \u201cworst (1\u201310) to serious (41\u201350)\u201d and \u201cmoderate (51\u201360) to superior (91\u2013100),\u201d according to the Global Assessment of Functioning Scale; and insight as poor (\u22648) and good (\u22659) according to the Insight Scale (Birchwood). Univariate and multivariable analyses were used to generate results.<\/jats:p><jats:p>Out of 126 subjects, 98 (78%) completed follow-up, of which 70 (71.4%) achieved symptomatic remission within mean duration of 8.05 (4.54) months. Besides, having long DUP and separated\/divorced\/widowed (adjusted hazard ratio [aHR]\u200a=\u200a0.07, 95%CI\u200a=\u200a[0.01, 0.46]), long DUP and poor insight (aHR\u200a=\u200a0.18, 95%CI\u200a=\u200a[0.04, 0.89]), poor insight and separated\/divorced\/widowed (aHR\u200a=\u200a0.09, 95%CI\u200a=\u200a[0.01, 0.70]), deteriorating premorbid functioning (aHR\u200a=\u200a0.47, 95%CI\u200a=\u200a[0.23, 0.97]), family history of psychiatric disorders (aHR\u200a=\u200a0.52, 95%CI\u200a=\u200a(0.30, 0.93]), and being male (aHR\u200a=\u200a0.47, 95%CI\u200a=\u200a[0.24, 0.92]) delayed symptomatic remission.<\/jats:p><jats:p>These results propose that psychological interventions and social support for mental health problems are warranted and may enhance better response to antipsychotic medications among separated\/divorced\/widowed patients with long DUP or poor insight, and poor insight patients with long DUP. Deteriorating premorbid functioning, family history of psychiatric disorders and being male continue being important risk factors for poor odds of remission.<\/jats:p><\/jats:sec>","DOI":"10.1097\/md.0000000000013078","type":"journal-article","created":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T21:26:40Z","timestamp":1541539600000},"page":"e13078","source":"Crossref","is-referenced-by-count":11,"title":["Rate of and time to symptomatic remission in first-episode psychosis in Northern Malawi"],"prefix":"10.1097","volume":"97","author":[{"given":"Atipatsa Chiwanda","family":"Kaminga","sequence":"first","affiliation":[{"name":"Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, Hunan, China"},{"name":"Department of Mathematics and Statistics, Mzuzu University, Private Bag 201, Luwinga,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjie","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, Hunan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aizhong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, Hunan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Japhet","family":"Myaba","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Mental Health Research Section, Saint John of God Community Services, Mzuzu, Malawi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Banda","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Mental Health Research Section, Saint John of God Community Services, Mzuzu, Malawi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi Wu","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, Hunan, China"},{"name":"OMNI Research Group, Department of Obstetrics and Gynecology, Faculty of Medicine, University of Ottawa"},{"name":"Ottawa Hospital Research Institute, Clinical Epidemiology Program"},{"name":"School of Epidemiology, Public Health, and Preventive Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiongfeng","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, Hunan, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1176\/appi.ajp.160.11.2063","article-title":"Early prediction of antipsychotic response in schizophrenia","volume":"160","author":"Correll","year":"2003","journal-title":"Am J Psychiatry"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/YIC.0000000000000030","article-title":"A prospective, open-label study to evaluate symptomatic remission in schizophrenia with risperidone long-acting injectable in Korea","volume":"29","author":"Lee","year":"2014","journal-title":"Int Clin Psychopharmacol"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.psychres.2017.04.050","article-title":"Early clinical recovery in first-episode psychosis: symptomatic remission and its correlates at 1-year follow-up","volume":"254","author":"Simonsen","year":"2017","journal-title":"Psychiatry Res"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1017\/S0033291710002035","article-title":"The different trajectories of antipsychotic response: antipsychotics versus placebo","volume":"41","author":"Marques","year":"2011","journal-title":"Psychol Med"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.4088\/JCP.v67n1106","article-title":"Remission in first-episode psychosis: predictor variables and symptom improvement patterns","volume":"67","author":"Emsley","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1176\/ajp.149.9.1183","article-title":"Duration of psychosis and outcome in first-episode schizophrenia","volume":"149","author":"Loebel","year":"1992","journal-title":"Am J Psychiatry"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1017\/S0033291706007379","article-title":"Predictors of rate and time to remission in first-episode psychosis: a two-year outcome study","volume":"36","author":"Malla","year":"2006","journal-title":"Psychol Med"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1017\/S0033291717000435","article-title":"Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors","volume":"47","author":"Demjaha","year":"2017","journal-title":"Psychol Med"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"505","DOI":"10.31887\/DCNS.2014.16.4\/mcarbon","article-title":"Clinical predictors of therapeutic response to antipsychotics in schizophrenia","volume":"16","author":"Carbon","year":"2014","journal-title":"Dialogues Clin Neurosci"},{"issue":"(Suppl 1)","key":"R10-20230915","first-page":"1","article-title":"Atypical antipsychotics: recent research findings and applications to clinical practice: Proceedings of a symposium presented at the 29th Annual European College of Neuropsychopharmacology Congress, 19 September 2016, Vienna, Austria. Ther","volume":"7","author":"Murray","year":"2017","journal-title":"Adv Psychopharmacol"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/bmb\/ldv017","article-title":"Antipsychotic medication in schizophrenia: a review","volume":"114","author":"Lally","year":"2015","journal-title":"Br Med Bull"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1176\/appi.ajp.162.10.1785","article-title":"Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis","volume":"162","author":"Perkins","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/oxfordjournals.schbul.a033315","article-title":"Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort","volume":"24","author":"Wiersma","year":"1998","journal-title":"Schizophr Bull"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.psychres.2013.10.022","article-title":"Predictors of response to second generation antipsychotics in drug naive patients with schizophrenia: a 1 year follow-up study in Shanghai","volume":"215","author":"Zhang","year":"2014","journal-title":"Psychiatry Res"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1353\/hpu.2017.0070","article-title":"Clinical correlates of treatment response among patients with schizophrenia in a tertiary Nigerian hospital","volume":"28","author":"Ezeme","year":"2017","journal-title":"J Health Care Poor Underserved"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3109\/10673229.2012.747804","article-title":"Remission in schizophrenia: critical and systematic review","volume":"20","author":"AlAqeel","year":"2012","journal-title":"Harv Rev Psychiatry"},{"key":"R17-20230915","first-page":"87","article-title":"Predictors of outcome in the early course of first-episode psychosis","volume":"24","author":"Lizzette","year":"2010","journal-title":"Eur J Psychiatry"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1177\/0004867417700278","article-title":"Raising the standard of care in the treatment of schizophrenia: yes we can!","volume":"51","author":"Catts","year":"2017","journal-title":"Aust N Z J Psychiatry"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1600-0447.2012.01883.x","article-title":"Symptomatic and functional remission in patients with first-episode psychosis","volume":"126","author":"Verma","year":"2012","journal-title":"Acta Psychiatr Scand"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1177\/0269881116654698","article-title":"Early predictors of a clinical response at 8 weeks in patients with first-episode psychosis treated with paliperidone ER","volume":"30","author":"Chung","year":"2016","journal-title":"J Psychopharmacol"},{"key":"R21-20230915","first-page":"263","article-title":"Remission and employment status in schizophrenia and other psychoses: one-year prospective study in Croatian patients treated with risperidone long acting injection","volume":"28","author":"Mihaljevic-Peles","year":"2016","journal-title":"Psychiatr Danub"},{"key":"R22-20230915","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.eurpsy.2009.09.001","article-title":"Establishing remission and good clinical functioning in schizophrenia: predictors of best outcome with long-term risperidone long-acting injectable treatment","volume":"25","author":"Lambert","year":"2010","journal-title":"Eur Psychiatry"},{"key":"R23-20230915","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jpsychires.2012.03.017","article-title":"Regional differences in treatment response and three year course of schizophrenia across the world","volume":"46","author":"Novick","year":"2012","journal-title":"J Psychiatr Res"},{"key":"R24-20230915","first-page":"114","article-title":"The concepts of remission and recovery in schizophrenia","volume":"24","author":"Emsley","year":"2011","journal-title":"Curr Opin Psychiatry"},{"key":"R25-20230915","doi-asserted-by":"crossref","first-page":"503","DOI":"10.4172\/1994-8220.1000106","article-title":"Duration of untreated psychosis and associated factors in first episode psychosis in Mzuzu in Northern Malawi","volume":"17","author":"Chilale","year":"2014","journal-title":"Afr J Psychiatry"},{"key":"R31-20230915","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/schbul\/8.3.470","article-title":"Measurement of premorbid adjustment in chronic schizophrenia","volume":"8","author":"Cannon-Spoor","year":"1982","journal-title":"Schizophr Bull"},{"key":"R32-20230915","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/schbul\/22.2.257","article-title":"First-episode schizophrenia: II. Premorbid patterns by gender","volume":"22","author":"Larsen","year":"1996","journal-title":"Schizophr Bull"},{"key":"R33-20230915","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1600-0447.1994.tb01487.x","article-title":"A self-report insight scale for psychosis: reliability, validity and sensitivity to change","volume":"89","author":"Birchwood","year":"1994","journal-title":"Acta Psychiatr Scand"},{"key":"R34-20230915","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1192\/bjp.bp.106.024653","article-title":"Insight in psychosis: influence of cognitive ability and self-esteem","volume":"191","author":"Cooke","year":"2007","journal-title":"Br J Psychiatry"},{"key":"R35-20230915","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/NMD.0b013e31816a62b2","article-title":"Measurement of insight in patients with bipolar disorder: are self-rated scales developed for patients with schizophrenia applicable?","volume":"196","author":"Jonsdottir","year":"2008","journal-title":"J Nerv Ment Dis"},{"key":"R36-20230915","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1176\/ajp.150.9.1349","article-title":"Establishing the onset of psychotic illness","volume":"150","author":"Beiser","year":"1993","journal-title":"Am J Psychiatry"},{"key":"R37-20230915","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.schres.2014.10.025","article-title":"Reliability and validity of methods for measuring the duration of untreated psychosis: a quantitative review and meta-analysis","volume":"160","author":"Register-Brown","year":"2014","journal-title":"Schizophr Res"},{"key":"R38-20230915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2014.01.022","article-title":"Prospective relationship between duration of untreated psychosis and 13-year clinical outcome: a first-episode psychosis study","volume":"153","author":"Tang","year":"2014","journal-title":"Schizophr Res"},{"key":"R39-20230915","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.psychres.2014.05.046","article-title":"Duration of untreated psychosis (DUP) and the course of schizophrenia in a 20-year follow-up study","volume":"219","author":"Cechnicki","year":"2014","journal-title":"Psychiatry Res"},{"key":"R40-20230915","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/appi.ajp.162.3.441","article-title":"Remission in schizophrenia: proposed criteria and rationale for consensus","volume":"162","author":"Andreasen","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R42-20230915","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/biomet\/52.3-4.591","article-title":"An analysis of variance test for normality (complete samples)","volume":"52","author":"Shapiro","year":"1965","journal-title":"Biometrika"},{"key":"R43-20230915","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"R44-20230915","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/01621459.1977.10479903","article-title":"Covariance analysis of heart transplants survival data","volume":"72","author":"Crowley","year":"1977","journal-title":"J Am Stat Assoc"},{"key":"R45-20230915","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/sj.bjc.6601120","article-title":"Survival analysis Part III: multivariate data analysis\u2014choosing a model and assessing its adequacy and fit","volume":"89","author":"Bradburn","year":"2003","journal-title":"Br J Cancer"},{"key":"R46-20230915","first-page":"575","article-title":"Effect modification in epidemiology and medicine","volume":"15","author":"Kamangar","year":"2012","journal-title":"Arch Iran Med"},{"key":"R47-20230915","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1515\/em-2013-0005","article-title":"A Tutorial on Interaction","volume":"3","author":"VanderWeele","year":"2014","journal-title":"Epidemiol Methods"},{"key":"R48-20230915","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/schbul\/sbn029","article-title":"Clinical course and outcome of schizophrenia in a predominantly treatment\u2014naive cohort in rural Ethiopia","volume":"35","author":"Alem","year":"2009","journal-title":"Schizophr Bull"},{"key":"R49-20230915","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.schres.2011.10.021","article-title":"Five-year clinical course and outcome of schizophrenia in Ethiopia","volume":"136","author":"Teferra","year":"2012","journal-title":"Schizophr Res"},{"key":"R50-20230915","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1176\/appi.ps.201400558","article-title":"Early predictors of ten-year course in first-episode psychosis","volume":"67","author":"Friis","year":"2016","journal-title":"Psychiatr Serv"},{"key":"R51-20230915","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/schbul\/sbn143","article-title":"Clinical recovery in firste-episode psychosis","volume":"35","author":"Wunderink","year":"2009","journal-title":"Schizophr Bull"},{"key":"R52-20230915","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1590\/S0104-11692012000100008","article-title":"Relationship among social support, treatment adherence and metabolic control of diabetes mellitus patients","volume":"20","author":"Gomes-Villas Boas","year":"2012","journal-title":"Rev Lat Am Enfermagem"},{"key":"R53-20230915","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10865-008-9173-4","article-title":"The association of emotional well-being and marital status with treatment adherence among patients with hypertension","volume":"31","author":"Trivedi","year":"2008","journal-title":"J Behav Med"},{"key":"R54-20230915","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.hrtlng.2011.09.009","article-title":"Medication adherence mediates the relationship between marital status and cardiac event-free survival in patients with heart failure","volume":"41","author":"Wu","year":"2012","journal-title":"Heart Lung"},{"key":"R55-20230915","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.rpsm.2016.04.001","article-title":"Adherence predicts symptomatic and psychosocial remission in schizophrenia: Naturalistic study of patient integration in the community","volume":"10","author":"Bernardo","year":"2017","journal-title":"Rev Psiquiatr Salud Ment"},{"key":"R57-20230915","first-page":"18","article-title":"Treatment adherence and insight in schizophrenia","volume":"30","author":"Bitter","year":"2015","journal-title":"Psychiatr Hung"},{"key":"R58-20230915","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12888-015-0560-4","article-title":"Relationship of insight with medication adherence and the impact on outcomes in patients with schizophrenia and bipolar disorder: results from a 1-year European outpatient observational study","volume":"15","author":"Novick","year":"2015","journal-title":"BMC Psychiatry"},{"key":"R59-20230915","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1471-244X-11-152","article-title":"Early response predicts subsequent response to olanzapine long-acting injection in a randomized, double-blind clinical trial of treatment for schizophrenia","volume":"11","author":"Ascher-Svanum","year":"2011","journal-title":"BMC Psychiatry"},{"key":"R60-20230915","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1176\/appi.ajp.2015.14101329","article-title":"Early improvement as a predictor of later response to antipsychotics in schizophrenia: a diagnostic test review","volume":"172","author":"Samara","year":"2015","journal-title":"Am J Psychiatry"},{"key":"R61-20230915","doi-asserted-by":"crossref","first-page":"390","DOI":"10.5455\/bcp.20151128021707","article-title":"Prediction of response to antipsychotic drugs in schizophrenia patients within the early phase of treatment","volume":"25","author":"Yildiz","year":"2015","journal-title":"Klinik Psikofarmakol B\u00fclteni"},{"key":"R62-20230915","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1192\/bjp.178.6.506","article-title":"Recovery from psychotic illness: a 15- and 25-year international follow-up study","volume":"178","author":"Harrison","year":"2001","journal-title":"Br J Psychiatry"},{"key":"R63-20230915","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/13651501.2016.1141960","article-title":"Insight and recovery in schizophrenic patients","volume":"20","author":"Cannavo","year":"2016","journal-title":"Int J Psychiatry Clin Pract"},{"key":"R64-20230915","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1192\/bjp.bp.105.013276","article-title":"Premorbid functioning and treatment response in recent-onset schizophrenia","volume":"189","author":"Rabinowitz","year":"2018","journal-title":"Br J Psychiatry"},{"key":"R65-20230915","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/JCP.0b013e31820568c6","article-title":"Premorbid functioning and treatment response in recent-onset schizophrenia: prospective study with risperidone long-acting injectable","volume":"31","author":"Rabinowitz","year":"2011","journal-title":"J Clin Psychopharmacol"},{"key":"R66-20230915","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1192\/bjp.185.1.18","article-title":"Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders","volume":"185","author":"Perkins","year":"2004","journal-title":"Br J Psychiatry"},{"key":"R67-20230915","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/oxfordjournals.schbul.a007077","article-title":"Premorbid functioning in schizophrenia: relation to baseline symptoms, treatment response, and medication side effects","volume":"30","author":"Strous","year":"2004","journal-title":"Schizophr Bull"},{"key":"R68-20230915","doi-asserted-by":"crossref","first-page":"e1002973","DOI":"10.1371\/journal.pgen.1002973","article-title":"Comparison of family history and SNPs for predicting risk of complex disease","volume":"8","author":"Do","year":"2012","journal-title":"PLoS Genet"},{"key":"R69-20230915","doi-asserted-by":"crossref","first-page":"455","DOI":"10.31887\/DCNS.2014.16.4\/fmcmahon","article-title":"Prediction of treatment outcomes in psychiatry\u2014where do we stand ?","volume":"16","author":"McMahon","year":"2014","journal-title":"Dialogues Clin Neurosci"},{"key":"R70-20230915","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/gim.0b013e3182310bcf","article-title":"The family history: the first genetic test, and still useful after all those years?","volume":"14","author":"Pyeritz","year":"2012","journal-title":"Genet Med"},{"key":"R71-20230915","first-page":"95","article-title":"Prediction of lithium response in affective disorders","volume":"39","author":"Ananth","year":"1978","journal-title":"J Clin Psychiatry"},{"key":"R72-20230915","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.pnpbp.2013.02.009","article-title":"Prediction of acute clinical response following a first episode of non affective psychosis: Results of a cohort of 375 patients from the Spanish PAFIP study","volume":"44","author":"Crespo-Facorro","year":"2013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R73-20230915","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1517\/14656566.9.12.2027","article-title":"Incomplete remission and treatment resistance in first-episode psychosis: definition, prevalence and predictors","volume":"9","author":"Huber","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"R74-20230915","doi-asserted-by":"crossref","first-page":"7000","DOI":"10.1007\/s12035-018-0876-4","article-title":"Accessing gene expression in treatment-resistant schizophrenia","volume":"55","author":"Moretti","year":"2018","journal-title":"Mol Neurobiol"},{"key":"R75-20230915","first-page":"455","article-title":"The genetics of mental illness: implications for practice","volume":"78","author":"Hyman","year":"2000","journal-title":"Bull World Health Organ"},{"key":"R76-20230915","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1192\/bjp.bp.107.048942","article-title":"Beyond the critical period: longitudinal study of 8-year outcome in first-episode non-affective psychosis","volume":"194","author":"Crumlish","year":"2018","journal-title":"Br J Psychiatry"},{"key":"R77-20230915","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1176\/ajp.156.4.544","article-title":"Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder","volume":"156","author":"Robinson","year":"1999","journal-title":"Am J Psychiatry"},{"key":"R78-20230915","doi-asserted-by":"crossref","first-page":"e308","DOI":"10.4088\/JCP.13m08853","article-title":"Determinants of antipsychotic response in schizophrenia: implications for practice and future clinical trials","volume":"75","author":"Rabinowitz","year":"2014","journal-title":"J Clin Psychiatry"},{"issue":"(Suppl 1)","key":"R79-20230915","first-page":"S8","article-title":"New advances in pharmacotherapy for early psychosis","volume":"3","author":"Emsley","year":"2009","journal-title":"Early Interv Psychiatry"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201811090-00029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T04:07:39Z","timestamp":1720757259000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201811090-00029"}},"subtitle":["A STROBE-compliant article"],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":72,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000013078","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}